GRCB(01551): Zheng Guojian resigns as an independent non-executive director.
Guangzhou Rural Commercial Bank (01551) announced that Mr. Zheng Guojian, an independent non-executive director of the bank, has submitted his resignation letter to the board of directors due to the need to devote more time to other personal affairs. He has resigned from the positions of the fourth session of the board of directors, chairman and member of the Audit Committee, member of the Nomination and Remuneration Committee, and member of the Related Party Transactions and Risk Management Committee. According to the bank's articles of association, Mr. Zheng's resignation was approved by the board of directors on February 3, 2026, and took effect on the same day.
GRCB(01551) announced that Mr. Zheng Guojian, an independent non-executive director of the bank, has submitted his resignation letter to the board of directors due to the need to devote more time to other personal affairs. He has resigned from the positions of independent non-executive director, chairman and member of the audit committee, member of the nomination and remuneration committee, and member of the related party transactions and risk management committee of the fourth board of directors. In accordance with the company's articles of association, Mr. Zheng's resignation was approved by the board of directors on February 3, 2026, and took effect on the same day.
Related Articles

NATURAL BEAUTY(00157) announces a profit of approximately HK$8-10 million for the year, turning losses into profits compared to the previous year.

Pfizer Inc. (PFE.US) reported better-than-expected Q4 earnings, but investors are more concerned about whether the weight loss drug can support further growth.

GRACEWINE (08146) appoints Liu Yunqiang, Xiong Xia, and Zhao Mingjun as executive directors.
NATURAL BEAUTY(00157) announces a profit of approximately HK$8-10 million for the year, turning losses into profits compared to the previous year.

Pfizer Inc. (PFE.US) reported better-than-expected Q4 earnings, but investors are more concerned about whether the weight loss drug can support further growth.

GRACEWINE (08146) appoints Liu Yunqiang, Xiong Xia, and Zhao Mingjun as executive directors.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


